Alexander Fisher1, James Croft-Baker, Michael Davis
1Department of Geriatric Medicine, The Canberra Hospital, Canberra, Australia.
Two Parkinson's disease patients experienced liver damage from entacapone, a COMT inhibitor. Symptoms resolved after stopping the drug, suggesting a link between entacapone and hepatotoxicity in Parkinson's patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: